Phase II trials of tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia

Hady Ghanem, Hagop Kantarjian, Jorge Cortes, Alfonso Quintás-Cardama, Elias Jabbour

Research output: Contribution to journal › Review article › peer-review

Fingerprint

Dive into the research topics of 'Phase II trials of tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences

Social Sciences